HDAC6 and neuropathy: Treatment with Tubastatin A (TubA), an inhibitor of histone deacetylase 6 enzyme (HDAC6) previously shown to confer protection in mutant HSPB1-induced neuropathy [22], increased the levels of acetylated tubulin and restored the normal axonal transport of these organelles in Gan−/−DRG neurons.